MFVZX | RWMEX | MFVZX / RWMEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 23 years | - |
Gain YTD | 2.156 | 4.191 | 51% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 513M | 196B | 0% |
Annual Yield % from dividends | 1.22 | 1.45 | 84% |
Returns for 1 year | -2.54 | 7.81 | -32% |
Returns for 3 years | -6.61 | 17.24 | -38% |
Returns for 5 years | -0.55 | 36.81 | -1% |
Returns for 10 years | -13.24 | 59.59 | -22% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FRBRX | 132.46 | -0.77 | -0.58% |
Franklin Biotechnology Discovery R6 | |||
CIISX | 13.97 | -0.10 | -0.71% |
Causeway International Small Cap Instl | |||
EMAAX | 15.02 | -0.16 | -1.05% |
Gabelli Entpr Mergers & Acquisitions A | |||
MBCSX | 23.67 | -0.57 | -2.35% |
MassMutual Blue Chip Growth R5 | |||
MLACX | 4.38 | -0.11 | -2.45% |
NYLI Winslow Large Cap Growth Class C |